After a type 1.5 diabetes diagnosis in 2021, Lance Bass found a new path to health, balance, and saying yes to life.

DexCom, a global leader in glucose biosensing systems, stands out for its innovative continuous glucose monitoring (CGM) ...

Fintel reports that on May 30, 2025, Goldman Sachs initiated coverage of DexCom (NasdaqGS:DXCM) with a Buy recommendation.